Filed before 2025Filed 13 August 2019
Platelet BioGenesis, Inc. has sold $26.4M so far
Platelet BioGenesis, Inc., a company based in Cambridge, MA, has sold $26.4M so far in its equity round, according to a filing dated 13 August 2019.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 13 August 2019
- First filed
- 19 June 2019
- Round
- Equity round (amended filing)
- Amount sold
- $26.4M
- Offering size
- $26.4M
- Investors so far
- 34
- Based in
- Cambridge, MA
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
1 director of this company is named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 82% of the 1,781 tracked raises with an amount filed in 2019.
Platelet BioGenesis, Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 4 Nov 2021 | New filing | $35.4M | Another raise |
| 13 Aug 2019 | Amended filing | $26.4M | This raise |
| 19 Jun 2019 | New filing | $11.4M | This raise |
| 31 May 2017 | New filing | $10M | Another raise |
More with Qiming U.S. Healthcare on the board
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.